Landos Biopharma, Inc.
LABPDelisted May 23, 2024- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785345
Landos Biopharma, Inc. was delisted on May 23, 2024; its insiders filed their last Form 4 on May 23, 2024; 16 institutions reported holding it in 13F filings for Q1 2024, worth $34.9M in total; no superinvestor held it.
Q1 2022 vs. Q4 2021
How the institutions holding Landos Biopharma, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Of which not filed for Q1 2022 | Q1 2022 | Change |
|---|---|---|---|---|
| Holders | 40 | 1 | 45 | +6 |
| Shares | 24.9M | 408 | 23.9M | −1.04M (−4.2%) |
| Value | $119.8M | $2.00K | $35.3M | −$84.5M (−70.6%) |
1 institution that held it in Q4 2021 haven't filed for Q1 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (9)
Institutions that held Landos Biopharma, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bridgeway Capital Management, LLC | 159,000 | $235.0K | 0.00% |
| Jacobs Levy Equity Management, Inc | 158,875 | $234.0K | 0.00% |
| Millennium Management LLC | 60,968 | $90.0K | 0.00% |
| D. E. Shaw & Co., Inc. | 16,988 | $25.0K | 0.00% |
| FMR LLC | 1,383 | $2.00K | 0.00% |
| Barclays PLC | 761 | $1.00K | 0.00% |
| Amalgamated Bank | 802 | $1.00K | 0.00% |
| Advisor Group Holdings, Inc. | 418 | $1.00K | 0.00% |
| Amalgamated Financial Corp. | 802 | $1.00K | 0.00% |
Sold out (3)
Institutions that held Landos Biopharma, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Logos Global Management LP | 1,375,000 | $6.60M |
| Jump Financial, LLC | 15,200 | $73.0K |
| UBS Group AG | 3,805 | $18.0K |
Not filed for Q1 2022 yet (1)
Institutions that held Landos Biopharma, Inc. at the end of Q4 2021 and haven't filed a 13F for Q1 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Carroll Financial Associates, Inc. | 408 | $2.00K |